LENVATINIB

LENVATINIB CAPSULES 4 / 10 MG

Indication

For the first line treatment of patients with unresectable hepatocellular carcinoma. In combination with everolimus, for the treatment of patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy.

Pack

2 x 10 Alu Alu
Categories: ,

Note: Products are not marketed in countries where it is protected by Patent Law